Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms.
نویسندگان
چکیده
with the p.R110X mutation, as was described recently (13). Although p.R110X is one of the few recurrent mutations of this gene, we were unable to find other clinical descriptions of female patients carrying this mutation , and the movement disorder in CLS, although common, is not well studied. No clear hot spot mutations were found, thus highlighting the functional relevance of both protein kinase domains. In patients negative for RSK2 mutations by DHPLC analysis, direct sequencing of the entire gene failed to detect any variations. Moreover, no false-positive results were reported, each abnormal chromatogram containing 1 mutation or polymorphism. The detection rate in our patients was 7 of 16 (44%), and despite the small number of patients, we believe that it represents a significant increase in the sensitivity of RSK2 mutational screening compared with the recent literature. Among patients who were negative on RSK2 mutation analysis, only 2 exhibited a typical CLS phenotype. As suggested previously (14), genetic heterogeneity or defects in regions not investigated by this assay can account for the failure in detecting RSK2 mutations in those patients. Including the time to set up the PCR reaction and to perform the DHPLC, analysis time was ϳ6 h to screen the entire coding region of the RSK2 gene, thus providing a high-throughput alternative to single-strand conforma-tional polymorphism– based analysis for molecular pre-screening in CLS patients. We gratefully acknowledge financial support from the Italian Ministry of Health. Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations. Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction. et al. Unreported RSK2 missense mutation in two male sibs with an unusually mild form of Coffin-Lowry syndrome. Down syndrome is the most common chromosomal abnormality of live-born babies. Currently, cytogenetic analysis of fetal cells such as full chromosome karyotyping (1) and fluorescence in situ hybridization (2) are the most widely used techniques for prenatal diagnosis of this chromosomal aneuploidy. Recently, however, alternative molecular strategies have been developed. Quantitative fluorescence PCR involves the detection of short tandem repeats on chromosome 21 and is by far the most thoroughly evaluated molecular technique. Additional …
منابع مشابه
Single Nucleotide Polymorphisms and Association Studies: A Few Critical Points
Uncovering DNA sequence variations that correlate with phenotypic changes, e.g., diseases, is the aim of sequence variation studies. Common types sequence variations are Single nucleotide polymorphism (SNP, pronounced snip).SNPs are the third-generation molecular marker. SNP represents a DNA sequence variant of a single base pair with the minor allele occurring in more than 1% of a given popula...
متن کاملMass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms
Proteins can exist as multiple proteoforms in vivo, as a result of alternative splicing and single-nucleotide polymorphisms (SNPs), as well as posttranslational processing. To address their clinical significance in a context of diagnostic information, proteoforms require a more in-depth analysis. Mass spectrometric immunoassays (MSIA) have been devised for studying structural diversity in human...
متن کاملCell-free fetal DNA in the maternal serum and plasma: current and evolving applications.
PURPOSE OF REVIEW Free fetal nucleic acids, found in the plasma of every pregnant woman, have made a substantial impact on prenatal diagnosis. The past decade has seen the introduction of routine noninvasive prenatal diagnosis (NIPD) using DNA extracted from maternal plasma for a number of clinical complications of pregnancy, notably feto-maternal blood group incompatibility, fetal sexing and e...
متن کاملRapid detection of aneuploidy (trisomy 21) by allele quantification combined with melting curves analysis of single-nucleotide polymorphism loci.
BACKGROUND Molecular approaches for the detection of chromosomal abnormalities will allow the development of rapid, cost-effective screening strategies. We present here a molecular alternative for the detection of aneuploidies and, more specifically, trisomy 21. METHODS We used the quantitative value of melting curve analysis of heterozygous genetic loci to establish a relative allelic count....
متن کاملA novel procedure for efficient genotyping of single nucleotide polymorphisms.
Due to the surge in interest in using single nucleotide polymorphisms (SNPs) for genotyping a facile and affordable method for this is an absolute necessity. Here we introduce a procedure that combines an easily automatable single tube sample preparation with an efficient high throughput mass spectrometric analysis technique. Known point mutations or single nucleotide polymorphisms are easily a...
متن کاملValidation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.
OBJECTIVE To assess the performance of cell-free DNA (cfDNA) testing in maternal blood for detection of fetal aneuploidy of chromosomes 13, 18, 21, X, and Y using targeted sequencing of single-nucleotide polymorphisms. METHODS Prospective study in 242 singleton pregnancies undergoing chorionic villus sampling at 11 to 13 weeks. Maternal blood was collected before chorionic villus sampling and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical chemistry
دوره 51 12 شماره
صفحات -
تاریخ انتشار 2005